Rutin Protects Myocardial Ischemia–Reperfusion Injury via the NF-κB/NLRP3/Pyroptosis Pathway Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1021/acsomega.5c01408
This study aimed to determine the protective role and mechanism of rutin on myocardial ischemia-reperfusion (I/R) injury. First, a myocardial I/R injury model was established and subjected to ischemia and hypoxia to simulate the model of I/R injury in vivo. Triphenyltetrazolium chloride was used to determine the myocardial infarct area. Immunohistochemistry, the TUNEL assay, and hematoxylin and eosin staining were performed to determine NLRP3 expression, myocardial cell apoptosis, and cardiomyocyte morphology, respectively. Western blot analysis, the CCK-8 assay, and an ELISA were used to determine pyroptosis-associated protein expression, cell viability, and inflammatory factor expression, respectively. Rutin was shown to reduce the myocardial infarct area and myocardial cell apoptosis in vivo. Furthermore, rutin reduced the CK-MB, cTnT/I, and malondialdehyde levels after I/R injury. NLRP3 expression was downregulated after treatment with rutin compared to the sham group. NF-κB, NLRP3, cleaved caspase-1, and cleaved gasdermin D protein were also downregulated after rutin treatment. Rutin treatment enhanced cell viability after hypoxia-reperfusion conditions in in vitro experiments, reduced cell apoptosis, and reduced the LDH and ROS levels. Rutin also downregulated the expression of inflammatory factors (IL-1β, TNF-α, and IL-18) and pyroptosis-related proteins (NF-κB, NLRP3, cleaved caspase-1, and cleaved gasdermin D). Moreover, the protective effect of rutin on myocardial I/R injury disappeared after the NLRP3 agonist, nigericin, combined with rutin. These findings indicated that rutin protected myocardial I/R injury via the NF-κB/NLRP3/pyroptosis pathway and suggested a new treatment approach for myocardial I/R injury.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1021/acsomega.5c01408
- OA Status
- gold
- References
- 40
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4410424593
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4410424593Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1021/acsomega.5c01408Digital Object Identifier
- Title
-
Rutin Protects Myocardial Ischemia–Reperfusion Injury via the NF-κB/NLRP3/Pyroptosis PathwayWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-05-16Full publication date if available
- Authors
-
Kejun Tian, Lijuan Song, Liping Liu, Thomas T. Lai, Wenxia LiuList of authors in order
- Landing page
-
https://doi.org/10.1021/acsomega.5c01408Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1021/acsomega.5c01408Direct OA link when available
- Concepts
-
Pyroptosis, Rutin, Reperfusion injury, NF-κB, Myocardial ischemia, Ischemia, Medicine, Myocardial Reperfusion Injury, Pharmacology, Chemistry, Cardiology, Internal medicine, Inflammation, Inflammasome, Biochemistry, AntioxidantTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
40Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4410424593 |
|---|---|
| doi | https://doi.org/10.1021/acsomega.5c01408 |
| ids.doi | https://doi.org/10.1021/acsomega.5c01408 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40488073 |
| ids.openalex | https://openalex.org/W4410424593 |
| fwci | 0.0 |
| type | article |
| title | Rutin Protects Myocardial Ischemia–Reperfusion Injury via the NF-κB/NLRP3/Pyroptosis Pathway |
| biblio.issue | 21 |
| biblio.volume | 10 |
| biblio.last_page | 21785 |
| biblio.first_page | 21777 |
| grants[0].funder | https://openalex.org/F4320326689 |
| grants[0].award_id | 202310728 |
| grants[0].funder_display_name | Health and Family Planning Commission of Jiangxi Province |
| topics[0].id | https://openalex.org/T11078 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | Inflammasome and immune disorders |
| topics[1].id | https://openalex.org/T11139 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9922999739646912 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2727 |
| topics[1].subfield.display_name | Nephrology |
| topics[1].display_name | Gout, Hyperuricemia, Uric Acid |
| topics[2].id | https://openalex.org/T10294 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9909999966621399 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Cell death mechanisms and regulation |
| funders[0].id | https://openalex.org/F4320326689 |
| funders[0].ror | |
| funders[0].display_name | Health and Family Planning Commission of Jiangxi Province |
| is_xpac | False |
| apc_list.value | 1685 |
| apc_list.currency | USD |
| apc_list.value_usd | 1685 |
| apc_paid.value | 1685 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 1685 |
| concepts[0].id | https://openalex.org/C17172800 |
| concepts[0].level | 4 |
| concepts[0].score | 0.924104630947113 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q7263707 |
| concepts[0].display_name | Pyroptosis |
| concepts[1].id | https://openalex.org/C2775963812 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6879774928092957 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q407857 |
| concepts[1].display_name | Rutin |
| concepts[2].id | https://openalex.org/C2780114680 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6309247612953186 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1413991 |
| concepts[2].display_name | Reperfusion injury |
| concepts[3].id | https://openalex.org/C2777730290 |
| concepts[3].level | 3 |
| concepts[3].score | 0.619900107383728 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q411114 |
| concepts[3].display_name | NF-κB |
| concepts[4].id | https://openalex.org/C3017461755 |
| concepts[4].level | 3 |
| concepts[4].score | 0.4947482943534851 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q844935 |
| concepts[4].display_name | Myocardial ischemia |
| concepts[5].id | https://openalex.org/C541997718 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4911470115184784 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q188151 |
| concepts[5].display_name | Ischemia |
| concepts[6].id | https://openalex.org/C71924100 |
| concepts[6].level | 0 |
| concepts[6].score | 0.44267556071281433 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[6].display_name | Medicine |
| concepts[7].id | https://openalex.org/C2911020856 |
| concepts[7].level | 4 |
| concepts[7].score | 0.41208094358444214 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1413991 |
| concepts[7].display_name | Myocardial Reperfusion Injury |
| concepts[8].id | https://openalex.org/C98274493 |
| concepts[8].level | 1 |
| concepts[8].score | 0.3974258303642273 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[8].display_name | Pharmacology |
| concepts[9].id | https://openalex.org/C185592680 |
| concepts[9].level | 0 |
| concepts[9].score | 0.2697683572769165 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[9].display_name | Chemistry |
| concepts[10].id | https://openalex.org/C164705383 |
| concepts[10].level | 1 |
| concepts[10].score | 0.26631444692611694 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q10379 |
| concepts[10].display_name | Cardiology |
| concepts[11].id | https://openalex.org/C126322002 |
| concepts[11].level | 1 |
| concepts[11].score | 0.22939208149909973 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[11].display_name | Internal medicine |
| concepts[12].id | https://openalex.org/C2776914184 |
| concepts[12].level | 2 |
| concepts[12].score | 0.12207001447677612 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q101991 |
| concepts[12].display_name | Inflammation |
| concepts[13].id | https://openalex.org/C2777209026 |
| concepts[13].level | 3 |
| concepts[13].score | 0.11908143758773804 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q412405 |
| concepts[13].display_name | Inflammasome |
| concepts[14].id | https://openalex.org/C55493867 |
| concepts[14].level | 1 |
| concepts[14].score | 0.06991863250732422 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[14].display_name | Biochemistry |
| concepts[15].id | https://openalex.org/C2778004101 |
| concepts[15].level | 2 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q133948 |
| concepts[15].display_name | Antioxidant |
| keywords[0].id | https://openalex.org/keywords/pyroptosis |
| keywords[0].score | 0.924104630947113 |
| keywords[0].display_name | Pyroptosis |
| keywords[1].id | https://openalex.org/keywords/rutin |
| keywords[1].score | 0.6879774928092957 |
| keywords[1].display_name | Rutin |
| keywords[2].id | https://openalex.org/keywords/reperfusion-injury |
| keywords[2].score | 0.6309247612953186 |
| keywords[2].display_name | Reperfusion injury |
| keywords[3].id | https://openalex.org/keywords/nf-κb |
| keywords[3].score | 0.619900107383728 |
| keywords[3].display_name | NF-κB |
| keywords[4].id | https://openalex.org/keywords/myocardial-ischemia |
| keywords[4].score | 0.4947482943534851 |
| keywords[4].display_name | Myocardial ischemia |
| keywords[5].id | https://openalex.org/keywords/ischemia |
| keywords[5].score | 0.4911470115184784 |
| keywords[5].display_name | Ischemia |
| keywords[6].id | https://openalex.org/keywords/medicine |
| keywords[6].score | 0.44267556071281433 |
| keywords[6].display_name | Medicine |
| keywords[7].id | https://openalex.org/keywords/myocardial-reperfusion-injury |
| keywords[7].score | 0.41208094358444214 |
| keywords[7].display_name | Myocardial Reperfusion Injury |
| keywords[8].id | https://openalex.org/keywords/pharmacology |
| keywords[8].score | 0.3974258303642273 |
| keywords[8].display_name | Pharmacology |
| keywords[9].id | https://openalex.org/keywords/chemistry |
| keywords[9].score | 0.2697683572769165 |
| keywords[9].display_name | Chemistry |
| keywords[10].id | https://openalex.org/keywords/cardiology |
| keywords[10].score | 0.26631444692611694 |
| keywords[10].display_name | Cardiology |
| keywords[11].id | https://openalex.org/keywords/internal-medicine |
| keywords[11].score | 0.22939208149909973 |
| keywords[11].display_name | Internal medicine |
| keywords[12].id | https://openalex.org/keywords/inflammation |
| keywords[12].score | 0.12207001447677612 |
| keywords[12].display_name | Inflammation |
| keywords[13].id | https://openalex.org/keywords/inflammasome |
| keywords[13].score | 0.11908143758773804 |
| keywords[13].display_name | Inflammasome |
| keywords[14].id | https://openalex.org/keywords/biochemistry |
| keywords[14].score | 0.06991863250732422 |
| keywords[14].display_name | Biochemistry |
| language | en |
| locations[0].id | doi:10.1021/acsomega.5c01408 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210239500 |
| locations[0].source.issn | 2470-1343 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2470-1343 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | ACS Omega |
| locations[0].source.host_organization | https://openalex.org/P4310320006 |
| locations[0].source.host_organization_name | American Chemical Society |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320006 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | ACS Omega |
| locations[0].landing_page_url | https://doi.org/10.1021/acsomega.5c01408 |
| locations[1].id | pmid:40488073 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | ACS omega |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40488073 |
| locations[2].id | pmh:oai:europepmc.org:10951922 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | cc-by-nc-nd |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12138673 |
| locations[3].id | pmh:oai:doaj.org/article:6d28bf0cbe214a389a03f4495d88606a |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].source.host_organization_lineage | |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | ACS Omega, Vol 10, Iss 21, Pp 21777-21785 (2025) |
| locations[3].landing_page_url | https://doaj.org/article/6d28bf0cbe214a389a03f4495d88606a |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5100511053 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Kejun Tian |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210133784 |
| authorships[0].affiliations[0].raw_affiliation_string | The First Affiliated Hospital of Gannan Medical University |
| authorships[0].affiliations[1].raw_affiliation_string | Department of Cardiology |
| authorships[0].institutions[0].id | https://openalex.org/I4210133784 |
| authorships[0].institutions[0].ror | https://ror.org/040gnq226 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210133784 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | First Affiliated Hospital of Gannan Medical University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Kejun Tian |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Cardiology, The First Affiliated Hospital of Gannan Medical University |
| authorships[1].author.id | https://openalex.org/A5110121903 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Lijuan Song |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Cardiology |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I4210133784 |
| authorships[1].affiliations[1].raw_affiliation_string | The First Affiliated Hospital of Gannan Medical University |
| authorships[1].institutions[0].id | https://openalex.org/I4210133784 |
| authorships[1].institutions[0].ror | https://ror.org/040gnq226 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210133784 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | First Affiliated Hospital of Gannan Medical University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Lijuan Song |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Cardiology, The First Affiliated Hospital of Gannan Medical University |
| authorships[2].author.id | https://openalex.org/A5100352454 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2943-055X |
| authorships[2].author.display_name | Liping Liu |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I2801556517 |
| authorships[2].affiliations[0].raw_affiliation_string | Ruijin People’s Hospital |
| authorships[2].affiliations[1].raw_affiliation_string | Department of Cardiology |
| authorships[2].institutions[0].id | https://openalex.org/I2801556517 |
| authorships[2].institutions[0].ror | https://ror.org/01hv94n30 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I2801556517 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Ruijin Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Liping Liu |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Cardiology, Ruijin People’s Hospital |
| authorships[3].author.id | https://openalex.org/A5039862020 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Thomas T. Lai |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210119785 |
| authorships[3].affiliations[0].raw_affiliation_string | Shicheng County People’s Hospital |
| authorships[3].affiliations[1].raw_affiliation_string | Department of Cardiology |
| authorships[3].institutions[0].id | https://openalex.org/I4210119785 |
| authorships[3].institutions[0].ror | https://ror.org/02exfk080 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210119785 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Zoucheng People's Hospital |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Tao Lai |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Cardiology, Shicheng County People’s Hospital |
| authorships[4].author.id | https://openalex.org/A5048255524 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Wenxia Liu |
| authorships[4].countries | CN |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Pharmacy |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I141649914, https://openalex.org/I4210094836 |
| authorships[4].affiliations[1].raw_affiliation_string | Ganzhou People’s Hospital, The Affiliated Ganzhou Hospital of Nanchang University |
| authorships[4].institutions[0].id | https://openalex.org/I4210094836 |
| authorships[4].institutions[0].ror | https://ror.org/00r398124 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210094836 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | Ganzhou People's Hospital |
| authorships[4].institutions[1].id | https://openalex.org/I141649914 |
| authorships[4].institutions[1].ror | https://ror.org/042v6xz23 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I141649914 |
| authorships[4].institutions[1].country_code | CN |
| authorships[4].institutions[1].display_name | Nanchang University |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Wenxia Liu |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Pharmacy, Ganzhou People’s Hospital, The Affiliated Ganzhou Hospital of Nanchang University |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1021/acsomega.5c01408 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Rutin Protects Myocardial Ischemia–Reperfusion Injury via the NF-κB/NLRP3/Pyroptosis Pathway |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11078 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | Inflammasome and immune disorders |
| related_works | https://openalex.org/W4238347985, https://openalex.org/W4395043615, https://openalex.org/W4404394293, https://openalex.org/W4214613063, https://openalex.org/W3028778370, https://openalex.org/W2357886269, https://openalex.org/W2388745825, https://openalex.org/W3192290946, https://openalex.org/W570424866, https://openalex.org/W145362918 |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1021/acsomega.5c01408 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210239500 |
| best_oa_location.source.issn | 2470-1343 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2470-1343 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | ACS Omega |
| best_oa_location.source.host_organization | https://openalex.org/P4310320006 |
| best_oa_location.source.host_organization_name | American Chemical Society |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320006 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | ACS Omega |
| best_oa_location.landing_page_url | https://doi.org/10.1021/acsomega.5c01408 |
| primary_location.id | doi:10.1021/acsomega.5c01408 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210239500 |
| primary_location.source.issn | 2470-1343 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2470-1343 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | ACS Omega |
| primary_location.source.host_organization | https://openalex.org/P4310320006 |
| primary_location.source.host_organization_name | American Chemical Society |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320006 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | ACS Omega |
| primary_location.landing_page_url | https://doi.org/10.1021/acsomega.5c01408 |
| publication_date | 2025-05-16 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4386203906, https://openalex.org/W4388968044, https://openalex.org/W4301594839, https://openalex.org/W4375951458, https://openalex.org/W4388776088, https://openalex.org/W4381548955, https://openalex.org/W4225416470, https://openalex.org/W4283025527, https://openalex.org/W3161208341, https://openalex.org/W2992082558, https://openalex.org/W2888957013, https://openalex.org/W3110200930, https://openalex.org/W4392197161, https://openalex.org/W4385294805, https://openalex.org/W2896022297, https://openalex.org/W3083270987, https://openalex.org/W4224119964, https://openalex.org/W4386929978, https://openalex.org/W4220667319, https://openalex.org/W2786286611, https://openalex.org/W2900898897, https://openalex.org/W4392712138, https://openalex.org/W4389428814, https://openalex.org/W2781279551, https://openalex.org/W4390484444, https://openalex.org/W3082419883, https://openalex.org/W4327737680, https://openalex.org/W3212038085, https://openalex.org/W2753112695, https://openalex.org/W2530651900, https://openalex.org/W4382459103, https://openalex.org/W2548671536, https://openalex.org/W3092924953, https://openalex.org/W4401361151, https://openalex.org/W4384637033, https://openalex.org/W4308206074, https://openalex.org/W4212962259, https://openalex.org/W4381187922, https://openalex.org/W4386688043, https://openalex.org/W4220985942 |
| referenced_works_count | 40 |
| abstract_inverted_index.D | 142 |
| abstract_inverted_index.a | 18, 229 |
| abstract_inverted_index.an | 79 |
| abstract_inverted_index.in | 38, 108, 158 |
| abstract_inverted_index.of | 10, 35, 177, 199 |
| abstract_inverted_index.on | 12, 201 |
| abstract_inverted_index.to | 3, 27, 31, 44, 61, 83, 98, 131 |
| abstract_inverted_index.D). | 194 |
| abstract_inverted_index.I/R | 20, 36, 120, 203, 221, 235 |
| abstract_inverted_index.LDH | 168 |
| abstract_inverted_index.ROS | 170 |
| abstract_inverted_index.and | 8, 25, 29, 54, 56, 68, 78, 90, 104, 116, 139, 165, 169, 182, 184, 191, 227 |
| abstract_inverted_index.for | 233 |
| abstract_inverted_index.new | 230 |
| abstract_inverted_index.the | 5, 33, 46, 51, 75, 100, 113, 132, 167, 175, 196, 207, 224 |
| abstract_inverted_index.via | 223 |
| abstract_inverted_index.was | 23, 42, 96, 124 |
| abstract_inverted_index.This | 0 |
| abstract_inverted_index.also | 145, 173 |
| abstract_inverted_index.area | 103 |
| abstract_inverted_index.blot | 73 |
| abstract_inverted_index.cell | 66, 88, 106, 153, 163 |
| abstract_inverted_index.role | 7 |
| abstract_inverted_index.sham | 133 |
| abstract_inverted_index.that | 217 |
| abstract_inverted_index.used | 43, 82 |
| abstract_inverted_index.were | 59, 81, 144 |
| abstract_inverted_index.with | 128, 212 |
| abstract_inverted_index.(I/R) | 15 |
| abstract_inverted_index.<i>in | 159 |
| abstract_inverted_index.CCK-8 | 76 |
| abstract_inverted_index.ELISA | 80 |
| abstract_inverted_index.NLRP3 | 63, 122, 208 |
| abstract_inverted_index.Rutin | 95, 150, 172 |
| abstract_inverted_index.TUNEL | 52 |
| abstract_inverted_index.These | 214 |
| abstract_inverted_index.after | 119, 126, 147, 155, 206 |
| abstract_inverted_index.aimed | 2 |
| abstract_inverted_index.area. | 49 |
| abstract_inverted_index.eosin | 57 |
| abstract_inverted_index.model | 22, 34 |
| abstract_inverted_index.rutin | 11, 111, 129, 148, 200, 218 |
| abstract_inverted_index.shown | 97 |
| abstract_inverted_index.study | 1 |
| abstract_inverted_index.vivo. | 39, 109 |
| abstract_inverted_index.CK-MB, | 114 |
| abstract_inverted_index.First, | 17 |
| abstract_inverted_index.IL-18) | 183 |
| abstract_inverted_index.NLRP3, | 136, 188 |
| abstract_inverted_index.assay, | 53, 77 |
| abstract_inverted_index.effect | 198 |
| abstract_inverted_index.factor | 92 |
| abstract_inverted_index.group. | 134 |
| abstract_inverted_index.injury | 21, 37, 204, 222 |
| abstract_inverted_index.levels | 118 |
| abstract_inverted_index.reduce | 99 |
| abstract_inverted_index.rutin. | 213 |
| abstract_inverted_index.NF-κB, | 135 |
| abstract_inverted_index.TNF-α, | 181 |
| abstract_inverted_index.Western | 72 |
| abstract_inverted_index.cTnT/I, | 115 |
| abstract_inverted_index.cleaved | 137, 140, 189, 192 |
| abstract_inverted_index.factors | 179 |
| abstract_inverted_index.hypoxia | 30 |
| abstract_inverted_index.infarct | 48, 102 |
| abstract_inverted_index.injury. | 16, 121, 236 |
| abstract_inverted_index.levels. | 171 |
| abstract_inverted_index.pathway | 226 |
| abstract_inverted_index.protein | 86, 143 |
| abstract_inverted_index.reduced | 112, 162, 166 |
| abstract_inverted_index.(IL-1β, | 180 |
| abstract_inverted_index.(NF-κB, | 187 |
| abstract_inverted_index.agonist, | 209 |
| abstract_inverted_index.approach | 232 |
| abstract_inverted_index.chloride | 41 |
| abstract_inverted_index.combined | 211 |
| abstract_inverted_index.compared | 130 |
| abstract_inverted_index.enhanced | 152 |
| abstract_inverted_index.findings | 215 |
| abstract_inverted_index.ischemia | 28 |
| abstract_inverted_index.proteins | 186 |
| abstract_inverted_index.simulate | 32 |
| abstract_inverted_index.staining | 58 |
| abstract_inverted_index.Moreover, | 195 |
| abstract_inverted_index.analysis, | 74 |
| abstract_inverted_index.apoptosis | 107 |
| abstract_inverted_index.determine | 4, 45, 62, 84 |
| abstract_inverted_index.gasdermin | 141, 193 |
| abstract_inverted_index.indicated | 216 |
| abstract_inverted_index.mechanism | 9 |
| abstract_inverted_index.performed | 60 |
| abstract_inverted_index.protected | 219 |
| abstract_inverted_index.subjected | 26 |
| abstract_inverted_index.suggested | 228 |
| abstract_inverted_index.treatment | 127, 151, 231 |
| abstract_inverted_index.viability | 154 |
| abstract_inverted_index.vitro</i> | 160 |
| abstract_inverted_index.apoptosis, | 67, 164 |
| abstract_inverted_index.caspase-1, | 138, 190 |
| abstract_inverted_index.conditions | 157 |
| abstract_inverted_index.expression | 123, 176 |
| abstract_inverted_index.myocardial | 13, 19, 47, 65, 101, 105, 202, 220, 234 |
| abstract_inverted_index.nigericin, | 210 |
| abstract_inverted_index.protective | 6, 197 |
| abstract_inverted_index.treatment. | 149 |
| abstract_inverted_index.viability, | 89 |
| abstract_inverted_index.disappeared | 205 |
| abstract_inverted_index.established | 24 |
| abstract_inverted_index.expression, | 64, 87, 93 |
| abstract_inverted_index.hematoxylin | 55 |
| abstract_inverted_index.morphology, | 70 |
| abstract_inverted_index.Furthermore, | 110 |
| abstract_inverted_index.experiments, | 161 |
| abstract_inverted_index.inflammatory | 91, 178 |
| abstract_inverted_index.cardiomyocyte | 69 |
| abstract_inverted_index.downregulated | 125, 146, 174 |
| abstract_inverted_index.respectively. | 71, 94 |
| abstract_inverted_index.malondialdehyde | 117 |
| abstract_inverted_index.pyroptosis-related | 185 |
| abstract_inverted_index.hypoxia-reperfusion | 156 |
| abstract_inverted_index.Triphenyltetrazolium | 40 |
| abstract_inverted_index.ischemia-reperfusion | 14 |
| abstract_inverted_index.Immunohistochemistry, | 50 |
| abstract_inverted_index.pyroptosis-associated | 85 |
| abstract_inverted_index.NF-κB/NLRP3/pyroptosis | 225 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6000000238418579 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.17505094 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |